GRI
Price
$1.91
Change
-$0.06 (-3.05%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
4.8M
HOWL
Price
$1.87
Change
-$0.06 (-3.11%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
85.97M
28 days until earnings call
Interact to see
Advertisement

GRI vs HOWL

Header iconGRI vs HOWL Comparison
Open Charts GRI vs HOWLBanner chart's image
GRI Bio
Price$1.91
Change-$0.06 (-3.05%)
Volume$656
Capitalization4.8M
Werewolf Therapeutics
Price$1.87
Change-$0.06 (-3.11%)
Volume$39.34K
Capitalization85.97M
GRI vs HOWL Comparison Chart in %
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRI vs. HOWL commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRI is a Hold and HOWL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (GRI: $1.91 vs. HOWL: $1.88)
Brand notoriety: GRI and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRI: 18% vs. HOWL: 1165%
Market capitalization -- GRI: $4.8M vs. HOWL: $85.97M
GRI [@Biotechnology] is valued at $4.8M. HOWL’s [@Biotechnology] market capitalization is $85.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRI’s FA Score shows that 2 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • GRI’s FA Score: 2 green, 3 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, GRI is a better buy in the long-term than HOWL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRI’s TA Score shows that 6 TA indicator(s) are bullish while HOWL’s TA Score has 3 bullish TA indicator(s).

  • GRI’s TA Score: 6 bullish, 4 bearish.
  • HOWL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GRI is a better buy in the short-term than HOWL.

Price Growth

GRI (@Biotechnology) experienced а -4.98% price change this week, while HOWL (@Biotechnology) price change was -3.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Reported Earning Dates

HOWL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOWL($86M) has a higher market cap than GRI($4.8M). HOWL YTD gains are higher at: 27.027 vs. GRI (-86.437). GRI has higher annual earnings (EBITDA): -10.03M vs. HOWL (-66.34M). HOWL has more cash in the bank: 77.6M vs. GRI (5.12M). GRI has less debt than HOWL: GRI (96K) vs HOWL (37.1M). GRI (0) and HOWL (0) have equivalent revenues.
GRIHOWLGRI / HOWL
Capitalization4.8M86M6%
EBITDA-10.03M-66.34M15%
Gain YTD-86.43727.027-320%
P/E Ratio0.02N/A-
Revenue00-
Total Cash5.12M77.6M7%
Total Debt96K37.1M0%
FUNDAMENTALS RATINGS
GRI: Fundamental Ratings
GRI
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRIHOWL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
88%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALBBY15.96N/A
N/A
Alibaba Health Information Technology Ltd
CCOJF12.88N/A
N/A
Coca-Cola Bottlers Japan Inc.
FLFG9.00N/A
N/A
Federal Life Group, Inc.
VPHIF0.05N/A
N/A
Valeo Pharma Inc.
ORYZF3.61N/A
N/A
Oryzon Genomics SA

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with INAB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then INAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
-3.05%
INAB - GRI
40%
Loosely correlated
-2.03%
NLSP - GRI
38%
Loosely correlated
+1.91%
SNSE - GRI
37%
Loosely correlated
+1.99%
GOVX - GRI
37%
Loosely correlated
+5.48%
HOWL - GRI
33%
Poorly correlated
-2.59%
More